The Survey of Satisfaction in Chinese Rheumatologists and Patients With Rheumatoid Arthritis

Last updated: August 29, 2023
Sponsor: Chinese SLE Treatment And Research Group
Overall Status: Completed

Phase

N/A

Condition

Joint Injuries

Bone Diseases

Rheumatoid Arthritis

Treatment

TSQM-II

Clinical Study ID

NCT03483597
CRDC-satisfaction
  • Ages > 18
  • All Genders

Study Summary

A questionnaire for this research is designed, which initiated from TSQM-II treatment satisfaction questionnaire and based on research launched by rheumatology and immunology departments of Chinese 12 public tertiary hospitals distributed directionally by Chinese Rheumatism Data Center (CRDC). The research is about treatment satisfaction and its influencing factors for Chinese rheumatoid immunologists and rheumatoid arthritis (RA) patients as well as their expectations for treating this disease. This research will explore the matching degree between treatment satisfaction and expectation about rheumatoid arthritis from doctors and patients.

Eligibility Criteria

Inclusion

Inclusion Criteria: Doctors - registered rheumatoid specialist physicians subordinated to the 12 designatedhospitals Patients - aged over 18, confirming RA for more than 6 months

Exclusion

Exclusion Criteria: Doctors - N/A Patients - with Chinese reading comprehension barriers (unable to completethe questionnaire independently), without any RA treatment

Study Design

Total Participants: 1365
Treatment Group(s): 1
Primary Treatment: TSQM-II
Phase:
Study Start date:
March 31, 2018
Estimated Completion Date:
April 30, 2018

Study Description

In the last decade, China has made quick progress on treatment of rheumatoid arthritis. However, the improvement of remission rate cannot fully represent needs of patients for health. To meet health demands of patients and improve their satisfaction, an efficacy evaluation system based on the outcome report of patients should be established. A questionnaire for this research is designed and mended in view of TSQM-II treatment satisfaction questionnaire and the actual situation of RA diagnosis and treatment in China. An investigation on treatment satisfaction and its influencing factors for Chinese rheumatoid immunologists and rheumatoid arthritis (RA) patients as well as their expectations for this disease is carried out based on 120 rheumatoid immunologists and 1,200 rheumatoid arthritis patients (1:10) from Chinese 12 public tertiary hospitals distributed directionally by Chinese Rheumatism Data Center (CRDC). The research concludes rheumatoid specialist physicians for doctor population, and persons aged over 18 for patient population who has been confirmed as RA for 6 months above, excluding patients with Chinese reading comprehension barriers or without any RA treatment. Finally, summarize and analyze the total score of satisfaction from doctors and patients, average score of doctors and patients for various medical demands, as well as the satisfaction of patients about communication and service during medical treatment.

Connect with a study center

  • Peking Union Medical College Hospital

    Beijing, 100730
    China

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.